Contrast injector firm Medrad has received Food and Drug Administration clearance for its SimpliCT interventional guidance system. SimpliCT uses a laser beam to improve accuracy of CT-guided puncture procedures, according to the Indianola, PA-based firm. Medrad is the exclusive distributor of SimpliCT, which is manufactured by Norwegian firm NeoRad.
By AuntMinnie.com staff writersJune 27, 2001
Related Reading
Medrad lands RPI deal, May 10, 2001
Medrad adapts Spectris for mobile use, March 14, 2001
Medrad enhances syringe kits, February 21, 2001
Medrad to distribute CT-Guide, January 24, 2001
Copyright © 2001 AuntMinnie.com
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
